Opus Genetics (IRD) Prepaid Assets (2010 - 2026)
Opus Genetics (IRD) reported Prepaid Assets of $3.9 million for Q1 2026, up 184.57% year-over-year from $1.4 million in Q1 2025, and up 119.63% on a QoQ basis from $1.8 million in Q4 2025.
Opus Genetics (IRD) has 17 years of Prepaid Assets data on file, last reported at $3.9 million in Q1 2026.
- Quarterly Prepaid Assets rose 184.57% year-over-year to $3.9 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $3.9 million (up 184.57% YoY) and the FY2025 annual result came in at $1.8 million, up 247.18% from the prior year.
- Prepaid Assets improved to $3.9 million in Q1 2026 per IRD's latest filing, from $1.8 million in the prior quarter.
- Across five years, Prepaid Assets topped out at $3.9 million in Q1 2026 and bottomed at $45000.0 in Q2 2023.
- The 5-year median for Prepaid Assets is $1.0 million (2023), against an average of $1.0 million.
- The widest annual swing landed in 2023, when Prepaid Assets plunged 93.92%; it then jumped 2182.22% in 2024.
- Tracing IRD's Prepaid Assets over 5 years: stood at $1.5 million in 2022, then fell by 24.36% to $1.1 million in 2023, then slumped by 53.14% to $515000.0 in 2024, then jumped by 247.18% to $1.8 million in 2025, then surged by 119.63% to $3.9 million in 2026.
- Per Business Quant, the three latest IRD Prepaid Assets figures stand at $3.9 million (Q1 2026), $1.8 million (Q4 2025), and $815000.0 (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Opus Genetics | 357.99 Mn | 298.03 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 3.93 Mn |
| Dec 31, 2025 | 1.79 Mn |
| Sep 30, 2025 | 815,000.00 |
| Jun 30, 2025 | 1.43 Mn |
| Mar 31, 2025 | 1.38 Mn |
| Dec 31, 2024 | 515,000.00 |
| Sep 30, 2024 | 343,000.00 |
| Jun 30, 2024 | 1.03 Mn |
| Mar 31, 2024 | 89,000.00 |
| Dec 31, 2023 | 1.10 Mn |
| Sep 30, 2023 | 51,000.00 |
| Jun 30, 2023 | 45,000.00 |
| Mar 31, 2023 | 1.01 Mn |
| Dec 31, 2022 | 1.45 Mn |
| Sep 30, 2022 | 544,000.00 |
| Jun 30, 2022 | 740,000.00 |
| Mar 31, 2022 | 1.10 Mn |
| Dec 31, 2021 | 71,000.00 |
| Sep 30, 2021 | 560,000.00 |
| Jun 30, 2021 | 883,000.00 |
| Mar 31, 2021 | 1.40 Mn |
| Dec 31, 2020 | 26,000.00 |
| Sep 30, 2020 | 573,635.00 |
| Jun 30, 2020 | 817,653.00 |
| Mar 31, 2020 | 290,756.00 |
| Dec 31, 2019 | 149,000.00 |
| Sep 30, 2019 | 722,217.00 |
| Jun 30, 2019 | 1.03 Mn |
| Mar 31, 2019 | 566,721.00 |
| Dec 31, 2018 | 1.17 Mn |
| Sep 30, 2018 | 634,221.00 |
| Jun 30, 2018 | 779,361.00 |
| Mar 31, 2018 | 491,643.00 |
| Dec 31, 2017 | 793,940.00 |
| Sep 30, 2017 | 666,054.00 |
| Jun 30, 2017 | 532,602.00 |
| Mar 31, 2017 | 541,006.00 |
| Dec 31, 2016 | 608,517.00 |
| Sep 30, 2016 | 675,341.00 |
| Jun 30, 2016 | 199,697.00 |
| Mar 31, 2016 | 946,061.00 |
| Dec 31, 2015 | 1.22 Mn |
| Sep 30, 2015 | 675,220.00 |
| Jun 30, 2015 | 1.28 Mn |
| Mar 31, 2015 | 991,027.00 |
| Dec 31, 2014 | 361,176.00 |
| Sep 30, 2014 | 757,503.00 |
| Jun 30, 2014 | 901,297.00 |
| Mar 31, 2014 | 725,469.00 |
| Dec 31, 2013 | 37,760.00 |
| Sep 30, 2013 | 523,117.00 |
| Jun 30, 2013 | 390,671.00 |
| Mar 31, 2013 | 170,178.00 |
| Dec 31, 2012 | 175,990.00 |
| Sep 30, 2012 | 218,026.00 |
| Jun 30, 2012 | 274,820.00 |
| Mar 31, 2012 | 287,252.00 |
| Dec 31, 2011 | 333,171.00 |
| Sep 30, 2011 | 455,709.00 |
| Jun 30, 2011 | 486,098.00 |
| Dec 31, 2010 | 706,649.00 |